Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Stella Redpath"'
Autor:
Olivia Foroughi, Shaheen Madraswala, Jennifer Hayes, Kara Glover, Liam Lee, Moumita Chaki, Stella Redpath, Agnes Weixuan Yu, David Chiu, Kristen Garner Amanti, Gary Gustavsen
Publikováno v:
Journal of Personalized Medicine, Vol 13, Iss 8, p 1228 (2023)
Despite the OlympiA trial demonstrating that early-stage, high-risk, HER2- germline BRCA1 and BRCA2 mutation (gBRCAm) positive breast cancer patients can benefit from PARPi in the adjuvant setting, the gBRCA testing rate in early-stage HR+/HER2− pa
Externí odkaz:
https://doaj.org/article/c02053644d6d4513830a1e20fd3e334a
Autor:
Chaitanya S. Nirodi, John D. Minna, Jerry W. Shay, Adi F. Gazdar, Luc Girard, Stella Redpath, Robert Graves, Michael Peyton, Michael D. Story, Mitsuo Sato, Amit K. Das
Supplementary Figure 1 from Non–Small Cell Lung Cancers with Kinase Domain Mutations in the Epidermal Growth Factor Receptor Are Sensitive to Ionizing Radiation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ae26b42a6852361d2f892b6a7ef8f72
https://doi.org/10.1158/0008-5472.22364823.v1
https://doi.org/10.1158/0008-5472.22364823.v1
Autor:
Chaitanya S. Nirodi, John D. Minna, Jerry W. Shay, Adi F. Gazdar, Luc Girard, Stella Redpath, Robert Graves, Michael Peyton, Michael D. Story, Mitsuo Sato, Amit K. Das
Non–small cell lung cancers (NSCLCs) bearing mutations in the tyrosine kinase domain (TKD) of the epidermal growth factor receptor (EGFR) often exhibit dramatic sensitivity to the EGFR tyrosine kinase inhibitors gefitinib and erlotinib. Ionizing ra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a554f9cb73df66f3467158937fd9ace4
https://doi.org/10.1158/0008-5472.c.6494373.v1
https://doi.org/10.1158/0008-5472.c.6494373.v1
Autor:
Chaitanya S. Nirodi, John D. Minna, Jerry W. Shay, Adi F. Gazdar, Luc Girard, Stella Redpath, Robert Graves, Michael Peyton, Michael D. Story, Mitsuo Sato, Amit K. Das
Supplementary Figure 2 from Non–Small Cell Lung Cancers with Kinase Domain Mutations in the Epidermal Growth Factor Receptor Are Sensitive to Ionizing Radiation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14a6c261267e6bd49ec152e6c28c4fa1
https://doi.org/10.1158/0008-5472.22364820.v1
https://doi.org/10.1158/0008-5472.22364820.v1
Autor:
Chaitanya S. Nirodi, John D. Minna, Jerry W. Shay, Adi F. Gazdar, Luc Girard, Stella Redpath, Robert Graves, Michael Peyton, Michael D. Story, Mitsuo Sato, Amit K. Das
Supplementary Figure Legends 1-3 from Non–Small Cell Lung Cancers with Kinase Domain Mutations in the Epidermal Growth Factor Receptor Are Sensitive to Ionizing Radiation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bceff0da6e4487e63f7bf9b26b9cbee
https://doi.org/10.1158/0008-5472.22364814
https://doi.org/10.1158/0008-5472.22364814
Autor:
Yan Xiao, Denise Croix, Timothy Craig Allen, Julia Engstrom-Melnyk, Eric H. Bernicker, Stella Redpath, Baiyu Yang, Anup Abraham, R. Shah
Publikováno v:
Archives of Pathology & Laboratory Medicine. 146:975-983
Context.— With multiple therapeutic options available for patients with advanced non–small cell lung cancer, the timely ordering and return of results to determine therapy are of critical importance. Objective.— To assess factors impacting anap
Autor:
Eric H. Bernicker, Julia Engstrom-Melynk, Baiyu Yang, Yan Xiao, Denise Croix, Stella Redpath, Jaya Madala, R. Shah, Timothy Craig Allen, Anup Abraham
Publikováno v:
Oncotarget
Objective: This study assessed the prevalence of anaplastic lymphoma kinase (ALK) rearrangements in US oncology practices. Materials and Methods: Using a nationwide real-world database, we included adults with advanced non-small cell lung cancer (aNS
Autor:
Denise Croix, Timothy Craig Allen, Yan Xiao, R. Shah, Stella Redpath, Eric H. Bernicker, Julia Engstrom-Melnyk, Anup Abraham, Jaya Madala, Baiyu Yang
Publikováno v:
The Oncologist
Background National Comprehensive Cancer Network (NCCN) guidelines recommend biomarker testing as the first step in the management of patients with advanced non‐small cell lung cancer (aNSCLC). We assessed anaplastic lymphoma kinase (ALK) testing r
Publikováno v:
The journal of applied laboratory medicine. 6(2)
Autor:
A. Abraham, Julia Engstrom-Melnyk, Timothy Craig Allen, R. Shah, Yan Xiao, Denise Croix, Baiyu Yang, Eric H. Bernicker, Stella Redpath
Publikováno v:
Journal of Thoracic Oncology. 16:S11